Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) has issued an update.
Concord Healthcare Group Co., Ltd. has announced the abolition of its Supervisory Committee, with its functions to be assumed by the Audit Committee of the Board. This decision, in line with the latest legal provisions and the company’s situation, also involves proposed amendments to the Articles of Association and procedural rules for meetings, which will be subject to shareholder approval. The Board believes these changes are in the best interest of the company and its shareholders, aiming to streamline governance and enhance operational efficiency.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$2.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the healthcare industry. The company focuses on providing healthcare services and products, with a market presence that aligns with the regulations and guidelines of the People’s Republic of China.
Average Trading Volume: 5,461,772
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.04B
See more data about 2453 stock on TipRanks’ Stock Analysis page.